About Vipragen
Vipragen is a Healthcare company based in Bengaluru (India) founded in 2012 by Chandrashekaran Siddamadappa and Umesh Devurkar. Drug discovery and development services are provided for pharmaceuticals. Vipragen has raised $1.48 million across 6 funding rounds from investors including Conscience Multi Family Office, Startup Karnataka and KITVEN. The company has 75 employees. Vipragen was last valued at $5.7 million in May 2019. Its Indian entity Vipragen Biosciences Private Limited reported revenue of ₹18.35 Cr. Its focus areas include Biopharma Outsourcing, CRO and Drug Discovery.
Company details
The company was founded in 2012 in Bengaluru, India, within the pharmaceutical sector. Drug discovery and development services are offered, focusing on evaluation of potential compounds for safety and effectiveness. Operations cover the full spectrum from target validation to clinical candidature, supported by molecular modeling. Thorough testing is conducted to advance compounds through the development process.
- Headquarters Bengaluru, India
- Employees 75
- Founders Chandrashekaran Siddamadappa, Umesh Devurkar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vipragen.com
- Social LinkedIn
- Legal Name Vipragen Biosciences Private Limited
- Date of Incorporation 11 May, 2012
- Jurisdiction Mysore, Karnataka, India
- Annual Revenue₹18.35 Cr
FY 2025 · +46% YoY
- Net Profit₹4.28 Cr
FY 2025 · 23% margin
- EBITDA₹3.59 Cr
FY 2025 · 20% margin
- Total Equity Funding$1.48M (USD)
in 6 rounds
- InvestorsConscience Multi Family Office
& 17 more
- Employee Count75
Associated legal entities of Vipragen
Vipragen operates through Vipragen Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vipragen Biosciences Private Limited CIN U73100KA2012PTC063955 | Active | 11 May 2012 | Mysore, Karnataka | ₹18.3 Cr | 75 | 6 | View details |
Funding Insights of Vipragen
Vipragen has successfully raised a total of $1.48M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.48M
- Total Rounds 6
- First Round $207,895
(Jul 2017)
- Investors Count 18
All 6 funding rounds of Vipragen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | Series A | – | Conscience Multi Family Office | ||
| May 2019 | $657,889 | Seed | $5.7M | KITVEN | |
| May 2018 | $343,602 | Seed | $5.54M | Rustum Sam Boyce | |
| Jan 2018 | $269,143 | Seed | $••••• | Veena Rao, Somesh Datt Sharma | |
| Aug 2017 | Grant | – | – | ||
| Jul 2017 | $207,895 | Seed | $••••• | Chaitra Harsha |
| Date | Valuation | Stage |
|---|---|---|
| May 2019 | $5.7M | •••••••• |
| May 2018 | $5.54M | •••••••• |
| Jan 2018 | $••••• | •••••••• |
Full valuation and stage history of Vipragen
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $5.7M (May 2019). 18 investors in total: 4 institutional and 14 angel.
Investors in Vipragen
Vipragen has secured backing from 18 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Conscience Multi Family Office, Startup Karnataka and KITVEN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by government financial institutions focused on early and growth stage startups | 1999 | kitven.in | Bengaluru, India | |
Offers wealth management, estate planning, tax reduction, and insurance services to families. | 2019 | consciencemfo.com | Chennai, India | |
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
PU Pratibha Umesh Devurkar | unknown_5939e10ea60949658 | |||
KS K S Manjunath Naidu | unknown_35de67c9ce354f109 | |||
KS K Srinivasa Babu | unknown_985897afc4bc4b1ca | |||
KS K S Manjunath Naidu | unknown_cc667b9af476485fa | |||
CV Chandukudlu Vinodkumar | unknown_0171dc6749484af38 | |||
RS Rustum Sam Boyce | unknown_37995d1cdab54629b | |||
CH Chaitra Harsha | unknown_5240404f961643db9 |
Investor details for Vipragen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vipragen Biosciences Private Limited (Vipragen)
Vipragen Biosciences Private Limited is the primary company behind Vipragen. The board of Vipragen Biosciences Private Limited currently have 6 directors; the longest-serving is Umesh Devurkar, appointed in 2012. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Umesh Devurkar DIN 06382944 | Director | 17 Sep 2012 | 14 yrs 1 mo | Vipragen Biosciences Private Limited |
| Kannasandra Pushpalatha DIN 01683405 | Director | 01 Jul 2014 | 12 yrs 4 mo | Vipragen Biosciences Private Limited |
| Siddamadappa Chandrashekaran DIN 01770678 | Managing Director | 05 Oct 2015 | 11 yrs 1 mo | Vipragen Biosciences Private Limited |
| Yashas DIN 08817972 | Director | 10 Feb 2021 | 5 yrs 8 mo | Vipragen Biosciences Private Limited |
| Pallavur Viswanathan Harikrishnan DIN 10339546 | Nominee Director | 03 Oct 2023 | 3 yrs 1 mo | Vipragen Biosciences Private Limited |
| Patlapati Harsha Samaraditya DIN 11266474 | Additional Director | 03 Nov 2025 | 1 yr | Vipragen Biosciences Private Limited |
People of Vipragen
2 people are tracked at Vipragen (2 in leadership); the tracked headcount is 75.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Managing Director | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Vipragen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vipragen
Figures of Vipragen Biosciences Private Limited, the primary company behind Vipragen, for FY 2025. Revenue was ₹18.35 Cr (+46% year on year). Net profit was ₹4.28 Cr (23% margin). EBITDA was ₹3.59 Cr (20% margin). Revenue has grown at a compounded annual rate of +39% over three years and +56% over five years.
- ₹18.35 CrRevenue · FY 2025 · +46% YoY
- ₹4.28 CrNet profit · 23% margin
- ₹3.59 CrEBITDA · 20% margin
- ₹8.09 CrPaid-up capital
- 75Employees (provident fund records)
- +39%Revenue CAGR, 3 years
- +56%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vipragen Biosciences Private Limited are on its company page.
Detailed financial statements for Vipragen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Vipragen
4 dated milestones of Vipragen across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Vipragen is founded.
- Funding First funding round of $208K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A,.
Web traffic of Vipragen
The website of Vipragen (vipragen.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 7.2% vs previous month
Websites whose visitors overlap most with Vipragen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| advinus.com | 39% | 8.6K | #6,130,234 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Vipragen (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vipragen
Complete news archive for Vipragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vipragen
Vipragen was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Vipragen is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Vipragen is a funded company, having raised a total of $1.48M across 6 funding rounds to date. The company's 1st funding round was a Seed of $207.9K, raised on Jul 2017.
Vipragen has 75 employees.
The primary company behind Vipragen, Vipragen Biosciences Private Limited, reported revenue of ₹18.35 Cr for FY 2025, up 46% year on year.
The company was founded in 2012 in Bengaluru, India, within the pharmaceutical sector. Drug discovery and development services are offered, focusing on evaluation of potential compounds for safety and effectiveness. Operations cover the full spectrum from target validation to clinical candidature, supported by molecular modeling. Thorough testing is conducted to advance compounds through the development process.
Vipragen has 18 investors. Key investors include Conscience Multi Family Office, Startup Karnataka, KITVEN, Pratibha Umesh Devurkar, and K S Manjunath Naidu.
The valuation of Vipragen is $5.7M as of May 2019.
Vipragen operates through Vipragen Biosciences Private Limited.
The legal entities of Vipragen currently have 6 directors, including Umesh Devurkar, Pallavur Viswanathan Harikrishnan, Siddamadappa Chandrashekaran and others.